MassMutual Private Wealth & Trust’s SELLAS Life Sciences SLS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354	Buy	+24	New	+$166	﹤0.01%	2317

Other funds holding SLS

DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

FWA

Fulcrum Wealth Advisors Bellevue, Washington $131M AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's SLS Position: Q2 2026 in Review

MassMutual Private Wealth & Trust opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 24 shares worth $354. The stake represents ﹤0.01% of the portfolio and ranks #2317 among its holdings.

53 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

MassMutual Private Wealth & Trust held 24 shares of SELLAS Life Sciences worth $354 as of Q2 2026.
SELLAS Life Sciences was a new MassMutual Private Wealth & Trust position in Q2 2026.
SELLAS Life Sciences made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2317 holding.
53 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.